AzTrials
AzTrials

Pulp NecrosisNCT03763110

Photo-Activated Disinfection Versus Triple-Antibiotic Paste for Management of Necrotic Young Permanent Anterior Teeth

A study testing Photo Activated Disinfection and antibiotic paste in people with Pulp Necrosis, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to compare regenerative endodontics for necrotic young permanent anterior teeth using oral photo-activated disinfection versus triple antibiotic paste in terms of: 1. Clinical success in terms of absence of any complication such as spontaneous pain, sinus or swelling. 2. Read more about this study

Who is it for?
Ages 8 to 13 yearsHealthy volunteers can take part
Conditions the study is for
Pulp Necrosis
What is being tested?
Photo Activated Disinfection and antibiotic paste
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
15 Oct 2016to 15 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 13 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Healthy children with no physical, mental or systemic conditions.
  • Developmental age of the child is the most important factor so periapical x- ray will be taken first to assure apex immaturity.
  • No sex predilection.
  • Restorable necrotic young permanent anterior teeth

Who cannot join

  • Root fracture.
  • Internal or external root resorption.
  • Parents or guardians refuse to participate in the study.

About this study

Official title: Evaluation of Post-Operative Pain After Regenerative Endodontic Using Photo-Activated Oral Disinfection Versus Triple-Antibiotic Paste for Management of Necrotic Young Permanent Anterior Teeth

This study aims to compare regenerative endodontics for necrotic young permanent anterior teeth using oral photo-activated disinfection versus triple antibiotic paste in terms of:

  1. Clinical success in terms of absence of any complication such as spontaneous pain, sinus or swelling.
  2. Radiographic success in terms of healing of periapical radiolucency or increase root thickness, length or apical closure.
Read the detailed description

Disinfection of the root canal system is thought to be critical to the success of Regenerative Endodontic Procedures (REPs) as infection prevents regeneration, repair and stem cell activity . A suitable material for using as intra-canal medicament seems to be antibiotic. Triple antibiotic paste (TAP) containing metronidazole, ciprofloxacin and minocycline has been reported to be a successful regimen in controlling the root canal pathogen and in managing necrotic young permanent tooth .

Recently, new disinfection methods have been developed to overcome the limitations of conventional disinfecting protocols that they may neither reduce the number of bacteria to a satisfactory level nor minimize the toxicity to periapical stem/progenitors . Other concerns regarding the use of TAP are tooth discoloration after treatment and bacterial resistance. Photo-activated oral disinfection is a novel disinfection method which present a great solution for the problem associated with triple antibiotic paste

Conditions
Pulp Necrosis
Being tested
Photo Activated Disinfection, antibiotic paste
Medical subject headings
Dental Pulp Necrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Photo Activated DisinfectionDevice

    Also called Photodynamic therapy (PDT)

    Photoactivated disinfection (PAD) is based on the interaction of a photosensitive antibacterial agent and a light source. It uses a nontoxic dye [named photosensitizer PS] and low-intensity visible light. In oxygen presentation, these combine to produce some cytotoxic species. The PS molecules attach to bacteria membrane

  • antibiotic pasteDrug

    Also called Triple antibiotic paste

    An antibiotic mixture composed of ciprofloxacin, metronidazole, and minocycline, known as triple antibiotic paste (TAP) or "3mix", has been the most widely used medicament, This goes back to the studies by Hoshino et al.1996

Study groups in NCT03763110
Study groupRoleWhat they receive
Photo Activated DisinfectionExperimentalPhotoactivated disinfection (PAD) is based on the interaction of a photosensitive antibacterial agent and a light source. It uses a nontoxic dye [named photosensitizer PS] and low-intensity visible light. In oxygen presentation, these combine to produce some cytotoxic species. The PS molecules attach to bacteria membrane
Receives: Device: Photo Activated Disinfection
Antibiotic pasteActive comparatorHoshino et al. recommended a ratio of 1:1:1 of metronidazole (500 mg), minocycline (100 mg) and ciprofloxacin (200 mg) for the 3Mix formulation
Receives: Drug: antibiotic paste

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. absence of postoperative pain

    binary question by asking patients (yes or no)

    Measured: immediate post operative

  2. absence of postoperative pain

    binary question by asking patients (yes or no)

    Measured: at 3 months follow up

  3. absence of postoperative pain

    binary question by asking patients (yes or no)

    Measured: at 6 months follow up

  4. absence of postoperative pain

    binary question by asking patients (yes or no)

    Measured: at 9 months follow up

  5. absence of postoperative pain

    binary question by asking patients (yes or no)

    Measured: at 12 months follow up

Secondary outcomes (6)
  1. healing of sinus

    Clinical success in term of absence of sinus (Yes or No)

    Measured: immediate post operative, 3 months, 6 months, 9 months, 12 months

  2. healing of swelling

    Clinical success in term of absence of swelling (Yes or No)

    Measured: immediate post operative, 3 months, 6 months, 9 months, 12 months

  3. healing of periapical radiolucency

    Radiographic success in term of healing of periapical or radiolucency (Yes or No)

    Measured: baseline, 6 months, 12 months

  4. change in root length

    Radiographic evaluation by calibration of root length in millimetre by Digora

    Measured: baseline, 6 months, 12 months

  5. change in dentin root thickness

    Radiographic evaluation by calibration of root thickness in millimetre by Digora

    Measured: baseline, 6 months, 12 months

  6. change in apical diameter

    Radiographic evaluation by calibration of apical diameter in millimetre by Digora

    Measured: baseline, 6 months, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Dec 2018
  2. Study start15 Oct 2016
  3. Primary completion15 Dec 2018 (estimated)
  4. Study completion15 Apr 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03763110
Sponsor's protocol ID
Regenerative endodontic
Status last verified
Aug 2018
First submitted
17 Nov 2018
Last updated
5 Dec 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Photo Activated Disinfection and antibiotic paste in people with Pulp Necrosis, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

absence of postoperative pain (time frame: immediate post operative). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in